project id: TCGA-CESC; case submitter id: TCGA-EK-A2RC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.8; age at index: 33; days to birth: -12353; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1976; age at diagnosis: 12353; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 129.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 786; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: 0e8c70c9-1e73-4173-b82f-e5df1cae8bc2; sample submitter id: TCGA-EK-A2RC-01A; portion id: 0f05ea48-12a9-4002-a7a2-64ed04879d5b; portion submitter id: TCGA-EK-A2RC-01A-11; slide id: 11838234-0c42-4636-a22f-be2e0cecfc72; slide submitter id: TCGA-EK-A2RC-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 10.0; percent tumor cells: 84.0; percent tumor nuclei: 92.0; section location: TOP;